These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11545263)

  • 1. Cytoskeletal mechanisms of neuronal degeneration.
    Brandt R
    Cell Tissue Res; 2001 Aug; 305(2):255-65. PubMed ID: 11545263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau-induced neurodegeneration: a clue to its mechanism.
    del C Alonso A; Iqbal K
    J Alzheimers Dis; 2005 Dec; 8(3):223-6. PubMed ID: 16340080
    [No Abstract]   [Full Text] [Related]  

  • 3. Tau, neurodegeneration and Alzheimer's disease.
    Del Carmen Alonso A
    Curr Alzheimer Res; 2010 Dec; 7(8):653-5. PubMed ID: 21214513
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of connexins in neurodegenerative diseases (Review).
    Xing J; Xu C
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
    Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
    FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
    Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
    Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
    Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
    Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal transport and neurodegenerative disease.
    Chevalier-Larsen E; Holzbaur EL
    Biochim Biophys Acta; 2006; 1762(11-12):1094-108. PubMed ID: 16730956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system.
    Vickers JC; King AE; Woodhouse A; Kirkcaldie MT; Staal JA; McCormack GH; Blizzard CA; Musgrove RE; Mitew S; Liu Y; Chuckowree JA; Bibari O; Dickson TC
    Brain Res Bull; 2009 Oct; 80(4-5):217-23. PubMed ID: 19683034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach.
    Andjus PR; Bataveljić D; Vanhoutte G; Mitrecic D; Pizzolante F; Djogo N; Nicaise C; Gankam Kengne F; Gangitano C; Michetti F; van der Linden A; Pochet R; Bacić G
    Anat Rec (Hoboken); 2009 Dec; 292(12):1882-92. PubMed ID: 19943341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity.
    Yang C; Danielson EW; Qiao T; Metterville J; Brown RH; Landers JE; Xu Z
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6209-E6218. PubMed ID: 27681617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early involvement of the tegmentopontine reticular nucleus during the evolution of Alzheimer's disease-related cytoskeletal pathology.
    Rüb U; Schultz C; Del Tredici K; Braak H
    Brain Res; 2001 Jul; 908(2):107-12. PubMed ID: 11454320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
    Brandt R; Hundelt M; Shahani N
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
    Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
    Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegenerative diseases and model systems.
    Price DL; Borchelt DR; Wong PC; Pardo CA; Thinakaran G; Lee MK; Cleveland DW; Sisodia SS
    Cold Spring Harb Symp Quant Biol; 1996; 61():725-38. PubMed ID: 9246498
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis.
    Dasuri K; Zhang L; Keller JN
    Free Radic Biol Med; 2013 Sep; 62():170-185. PubMed ID: 23000246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tauopathy and Alzheimer disease: a full degenerating process].
    Buée L; Delacourte A
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
    Sorrentino G; Bonavita V
    Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanism.
    Hooper C; Killick R; Tavassoli M; Melino G; Lovestone S
    Neurosci Lett; 2006 Jun; 401(1-2):30-4. PubMed ID: 16580132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.
    Zhang M; Li J; Chakrabarty P; Bu B; Vincent I
    Am J Pathol; 2004 Sep; 165(3):843-53. PubMed ID: 15331409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.